Download PDF
Thorac Cardiovasc Surg 2015; 63(01): 002-020
DOI: 10.1055/s-0034-1378191
Review Article
Georg Thieme Verlag KG Stuttgart · New York

The Predictive Value of Platelet Function Point-of-Care Tests for Postoperative Blood Loss and Transfusion in Routine Cardiac Surgery: A Systematic Review

Mate Petricevic
1   Department of Cardiac Surgery, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
,
Tomislav Kopjar
1   Department of Cardiac Surgery, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
,
Bojan Biocina
1   Department of Cardiac Surgery, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
,
Davor Milicic
2   Department of Cardiovascular Diseases, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
,
Kresimir Kolic
3   Department of Medical Diagnostics, University of Split School of Medicine—University Hospital Center Split, Split, Croatia
,
Marko Boban
4   Department of Cardiology, University Hospital “Thalassotherapia Opatija,” Medical School University of Rijeka and Osijek, Opatija, Croatia
,
Bosko Skoric
2   Department of Cardiovascular Diseases, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
,
Ante Lekic
1   Department of Cardiac Surgery, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
,
Hrvoje Gasparovic
1   Department of Cardiac Surgery, University of Zagreb School of Medicine—University Hospital Center Zagreb, Zagreb, Croatia
› Author Affiliations
Further Information

Publication History

15 October 2013

14 March 2014

Publication Date:
01 July 2014 (online)

   Permissions and Reprints All articles of this category

Abstract

Excessive bleeding after cardiopulmonary bypass (CPB) operations remains to be a persistent problem and weak platelet function certainly contributes to bleeding diathesis. Antiplatelet therapy (APT) is an integral component of perioperative management in patients undergoing cardiac surgery procedures, both with and without use of CPB. In addition to individual variability in platelet function, different preoperative APT administration/discontinuation management further affects platelet function, which in turn may reflect bleeding tendency. However, the impact of drug-induced platelet inhibition on early postoperative bleeding extent remains difficult to predict. Herein, we reviewed the available evidence on the association between platelet function testing values and the extent of bleeding and transfusion requirements in early perioperative period. Currently, the association between platelet function measured by ex vivo assay and the occurrence of bleeding events remains uncertain. The intent of this review is to provide comprehensive literature insight into published evidence, investigating the possibility of platelet function tests to predict bleeding extent as well as transfusion requirements in cardiac surgery patients.

Keywords

blood transfusion - blood - coagulation/anticoagulation - coronary artery bypass grafts surgery
 

  • References

  • 1 Whitlock R, Crowther MA, Ng HJ. Bleeding in cardiac surgery: its prevention and treatment—an evidence-based review. Crit Care Clin 2005; 21 (3) 589-610
    CrossrefPubMedGoogle Scholar
  • 2 Christensen MC, Dziewior F, Kempel A, von Heymann C. Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26 (1) 46-51
    CrossrefPubMedGoogle Scholar
  • 3 Dixon B, Santamaria JD, Reid D , et al. The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME). Transfusion 2013; 53 (1) 19-27
    CrossrefPubMedGoogle Scholar
  • 4 Biancari F, Mikkola R, Heikkinen J, Lahtinen J, Kettunen U, Juvonen T. Individual surgeon's impact on the risk of re-exploration for excessive bleeding after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2012; 26 (4) 550-556
    CrossrefPubMedGoogle Scholar
  • 5 O'Donnell CJ, Larson MG, Feng D , et al; Framingham Heart Study. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 2001; 103 (25) 3051-3056
    CrossrefPubMedGoogle Scholar
  • 6 Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol 2009; 104 (2) 227-233
    CrossrefPubMedGoogle Scholar
  • 7 Mehta RH, Roe MT, Mulgund J , et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006; 48 (2) 281-286
    CrossrefPubMedGoogle Scholar
  • 8 Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987; 3 (1) 25-30
    CrossrefPubMedGoogle Scholar
  • 9 Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 2002; 16 (5) 545-550
    CrossrefPubMedGoogle Scholar
  • 10 Velik-Salchner C, Maier S, Innerhofer P , et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesth Analg 2009; 108 (6) 1747-1754
    CrossrefPubMedGoogle Scholar
  • 11 Fitchett D, Mazer CD, Eikelboom J, Verma S. Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications. Can J Cardiol 2013; 29 (9) 1042-1047
    CrossrefPubMedGoogle Scholar
  • 12 Smith PK, Goodnough LT, Levy JH , et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol 2012; 60 (5) 388-396
    CrossrefPubMedGoogle Scholar
  • 13 Jernberg T, Payne CD, Winters KJ , et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 2006; 27 (10) 1166-1173
    PubMedGoogle Scholar
  • 14 Bhatt DL, Stone GW, Mahaffey KW , et al; CHAMPION PHOENIX Investigators. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 2013; 368 (14) 1303-1313
    CrossrefPubMedGoogle Scholar
  • 15 Angiolillo DJ, Firstenberg MS, Price MJ , et al; BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012; 307 (3) 265-274
    CrossrefPubMedGoogle Scholar
  • 16 Casutt M, Konrad C, Schuepfer G. Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEM™. Anaesthesist 2012; 61 (11) 948-953
    CrossrefPubMedGoogle Scholar
  • 17 Nascimento B, Rizoli S, Rubenfeld G, Lin Y, Callum J, Tien HC. Design and preliminary results of a pilot randomized controlled trial on a 1:1:1 transfusion strategy: the trauma formula-driven versus laboratory-guided study. J Trauma 2011; 71 (5) (Suppl. 01) S418-S426
    CrossrefPubMedGoogle Scholar
  • 18 Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004; 30 (10) 1873-1881
    CrossrefPubMedGoogle Scholar
  • 19 Jackson GN, Ashpole KJ, Yentis SM. The TEG vs the ROTEM thromboelastography/thromboelastometry systems. Anaesthesia 2009; 64 (2) 212-215
    CrossrefPubMedGoogle Scholar
  • 20 Nielsen VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007; 18 (3) 247-252
    CrossrefPubMedGoogle Scholar
  • 21 Seidel H, Rahman MM, Scharf RE. Monitoring of antiplatelet therapy. Current limitations, challenges, and perspectives. Hamostaseologie 2011; 31 (1) 41-51
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Poston R, Gu J, Manchio J , et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 2005; 27 (4) 584-591
    CrossrefPubMedGoogle Scholar
  • 23 Carroll RC, Chavez JJ, Snider CC, Meyer DS, Muenchen RA. Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med 2006; 147 (4) 197-204
    CrossrefPubMedGoogle Scholar
  • 24 Preisman S, Kogan A, Itzkovsky K, Leikin G, Raanani E. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 2010; 37 (6) 1367-1374
    CrossrefPubMedGoogle Scholar
  • 25 Kwak YL, Kim JC, Choi YS, Yoo KJ, Song Y, Shim JK. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol 2010; 56 (24) 1994-2002
    CrossrefPubMedGoogle Scholar
  • 26 Weitzel NS, Weitzel LB, Epperson LE, Karimpour-Ford A, Tran ZV, Seres T. Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass. Anaesthesia 2012; 67 (10) 1158-1165
    CrossrefPubMedGoogle Scholar
  • 27 Mahla E, Suarez TA, Bliden KP , et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012; 5 (2) 261-269
    CrossrefPubMedGoogle Scholar
  • 28 Dunning J, Versteegh M, Fabbri A , et al; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008; 34 (1) 73-92
    CrossrefPubMedGoogle Scholar
  • 29 Wright RS, Anderson JL, Adams CD , et al. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57 (19) 1920-1959
    CrossrefPubMedGoogle Scholar
  • 30 Despotis GJ, Levine V, Filos KS , et al. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 1996; 85 (6) 1311-1323
    CrossrefPubMedGoogle Scholar
  • 31 Ereth MH, Nuttall GA, Klindworth JT , et al. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?. Anesth Analg 1997; 85 (2) 259-264
    CrossrefPubMedGoogle Scholar
  • 32 Ereth MH, Nuttall GA, Santrach PJ, Klindworth JT, Oliver Jr WC, Schaff HV. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass. Anesthesiology 1998; 88 (4) 962-969
    CrossrefPubMedGoogle Scholar
  • 33 Dietrich GV, Schueck R, Menges T, Kiesenbauer NP, Fruehauf AC, Marquardt I. Comparison of four methods for the determination of platelet function in whole blood in cardiac surgery. Thromb Res 1998; 89 (6) 295-301
    CrossrefPubMedGoogle Scholar
  • 34 Wahba A, Sander S, Birnbaum DE. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery?. Thorac Cardiovasc Surg 1998; 46 (4) 228-231
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Slaughter TF, Sreeram G, Sharma AD, El-Moalem H, East CJ, Greenberg CS. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 2001; 12 (2) 85-93
    CrossrefPubMedGoogle Scholar
  • 36 Forestier F, Coiffic A, Mouton C, Ekouevi D, Chêne G, Janvier G. Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant?. Br J Anaesth 2002; 89 (5) 715-721
    CrossrefPubMedGoogle Scholar
  • 37 Fattorutto M, Pradier O, Schmartz D, Ickx B, Barvais L. Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass?. Br J Anaesth 2003; 90 (5) 692-693
    CrossrefPubMedGoogle Scholar
  • 38 Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96 (1) 51-57 table of contents
    CrossrefPubMedGoogle Scholar
  • 39 Gerrah R, Brill A, Tshori S, Lubetsky A, Merin G, Varon D. Using cone and plate(let) analyzer to predict bleeding in cardiac surgery. Asian Cardiovasc Thorac Ann 2006; 14 (4) 310-315
    CrossrefPubMedGoogle Scholar
  • 40 Solomon C, Hartmann J, Osthaus A , et al. Platelet concentrates transfusion in cardiac surgery in relation to preoperative point-of-care assessment of platelet adhesion and aggregation. Platelets 2010; 21 (3) 221-228
    CrossrefPubMedGoogle Scholar
  • 41 Rahe-Meyer N, Winterhalter M, Boden A , et al. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaesthesiol Scand 2009; 53 (2) 168-175
    CrossrefPubMedGoogle Scholar
  • 42 Reece MJ, Klein AA, Salviz EA , et al. Near-patient platelet function testing in patients undergoing coronary artery surgery: a pilot study. Anaesthesia 2011; 66 (2) 97-103
    CrossrefPubMedGoogle Scholar
  • 43 Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8 (4) 283-298
    CrossrefPubMedGoogle Scholar
  • 44 Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D ; Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011; 91 (1) 123-129
    CrossrefPubMedGoogle Scholar
  • 45 Petricevic M, Biocina B, Milicic D , et al. Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery. J Thromb Thrombolysis 2013; 35 (1) 31-40
    CrossrefPubMedGoogle Scholar
  • 46 Petricevic M, Biocina B, Milicic D , et al. Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery. J Thromb Thrombolysis 2013; 36 (4) 514-526
    CrossrefPubMedGoogle Scholar
  • 47 Weber CF, Görlinger K, Meininger D , et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117 (3) 531-547
    CrossrefPubMedGoogle Scholar
  • 48 Schimmer C, Hamouda K, Sommer SP, Özkur M, Hain J, Leyh R. The predictive value of multiple electrode platelet aggregometry (multiplate) in adult cardiac surgery. Thorac Cardiovasc Surg 2013; 61 (8) 733-743
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Di Dedda U, Ranucci M, Baryshnikova E, Castelvecchio S ; Surgical and Clinical Outcome Research Group. Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg 2014; 45 (1) 165-170
    CrossrefPubMedGoogle Scholar
  • 50 Alström U, Granath F, Oldgren J, Ståhle E, Tydén H, Siegbahn A. Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery. Thromb Res 2009; 124 (5) 572-577
    CrossrefPubMedGoogle Scholar
  • 51 Rosengart TK, Romeiser JL, White LJ , et al. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration. J Thorac Cardiovasc Surg 2013; 146 (5) 1259-1266 , e1, discussion 1266
    CrossrefPubMedGoogle Scholar
  • 52 Petricevic M, Biocina B, Konosic S, Kopjar T, Kunac N, Gasparovic H. Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy. Heart Vessels 2013; 28 (1) 57-65
    CrossrefPubMedGoogle Scholar
  • 53 Gurbel PA, Tantry US. Drug insight: Clopidogrel nonresponsiveness. Nat Clin Pract Cardiovasc Med 2006; 3 (7) 387-395
    CrossrefPubMedGoogle Scholar
  • 54 Lordkipanidzé M, Diodati JG, Pharand C. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence. Pharmacol Ther 2009; 123 (2) 178-186
    CrossrefPubMedGoogle Scholar
  • 55 Sambu N, Warner T, Curzen N. Clopidogrel withdrawal: is there a “rebound” phenomenon?. Thromb Haemost 2011; 105 (2) 211-220
    PubMedGoogle Scholar
  • 56 Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth 2013; 27 (4, Suppl): S20-S34
    CrossrefPubMedGoogle Scholar
  • 57 Kim JH, Newby LK, Clare RM , et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am Heart J 2008; 156 (5) 886-892
    CrossrefPubMedGoogle Scholar
  • 58 Loor G, Vivacqua A, Sabik III JF , et al. Process improvement in cardiac surgery: development and implementation of a reoperation for bleeding checklist. J Thorac Cardiovasc Surg 2013; 146 (5) 1028-1032
    CrossrefPubMedGoogle Scholar
  • 59 Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg 2013; 145 (3, Suppl): S178-S185
    CrossrefPubMedGoogle Scholar
  • 60 Girdauskas E, Kempfert J, Kuntze T , et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010; 140 (5) 1117-1124 , e2
    CrossrefPubMedGoogle Scholar
  • 61 Hanke AA, Herold U, Dirkmann D, Tsagakis K, Jakob H, Görlinger K. Thromboelastometry Based Early Goal-Directed Coagulation Management Reduces Blood Transfusion Requirements, Adverse Events, and Costs in Acute Type A Aortic Dissection: A Pilot Study. Transfus Med Hemother 2012; 39 (2) 121-128
    CrossrefPubMedGoogle Scholar
  • 62 Lennon MJ, Gibbs NM, Weightman WM , et al. A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients. J Cardiothorac Vasc Anesth 2004; 18: 136-140
    CrossrefPubMedGoogle Scholar